ALNY
Price
$454.56
Change
+$3.33 (+0.74%)
Updated
Dec 1, 04:59 PM (EDT)
Capitalization
60.05B
73 days until earnings call
Intraday BUY SELL Signals
RPTX
Price
$2.13
Change
-$0.05 (-2.29%)
Updated
Dec 1, 04:59 PM (EDT)
Capitalization
91.56M
92 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ALNY vs RPTX

Header iconALNY vs RPTX Comparison
Open Charts ALNY vs RPTXBanner chart's image
Alnylam Pharmaceuticals
Price$454.56
Change+$3.33 (+0.74%)
Volume$12.82K
Capitalization60.05B
Repare Therapeutics
Price$2.13
Change-$0.05 (-2.29%)
Volume$2.86K
Capitalization91.56M
ALNY vs RPTX Comparison Chart in %
ALNY
Daily Signal:
Gain/Loss:
RPTX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ALNY vs. RPTX commentary
Dec 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALNY is a StrongBuy and RPTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 02, 2025
Stock price -- (ALNY: $451.23 vs. RPTX: $2.18)
Brand notoriety: ALNY and RPTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALNY: 54% vs. RPTX: 22%
Market capitalization -- ALNY: $60.05B vs. RPTX: $93.71M
ALNY [@Biotechnology] is valued at $60.05B. RPTX’s [@Biotechnology] market capitalization is $93.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALNY’s FA Score shows that 2 FA rating(s) are green whileRPTX’s FA Score has 0 green FA rating(s).

  • ALNY’s FA Score: 2 green, 3 red.
  • RPTX’s FA Score: 0 green, 5 red.
According to our system of comparison, ALNY is a better buy in the long-term than RPTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALNY’s TA Score shows that 5 TA indicator(s) are bullish while RPTX’s TA Score has 6 bullish TA indicator(s).

  • ALNY’s TA Score: 5 bullish, 5 bearish.
  • RPTX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, RPTX is a better buy in the short-term than ALNY.

Price Growth

ALNY (@Biotechnology) experienced а +3.40% price change this week, while RPTX (@Biotechnology) price change was +3.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.89%. For the same industry, the average monthly price growth was -0.60%, and the average quarterly price growth was +59.52%.

Reported Earning Dates

ALNY is expected to report earnings on Feb 12, 2026.

RPTX is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (+3.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALNY($60.1B) has a higher market cap than RPTX($91.6M). ALNY YTD gains are higher at: 91.760 vs. RPTX (66.412). ALNY has higher annual earnings (EBITDA): 187M vs. RPTX (-110.47M). ALNY has more cash in the bank: 2.73B vs. RPTX (109M). RPTX has less debt than ALNY: RPTX (649K) vs ALNY (1.31B). ALNY has higher revenues than RPTX: ALNY (3.21B) vs RPTX (250K).
ALNYRPTXALNY / RPTX
Capitalization60.1B91.6M65,611%
EBITDA187M-110.47M-169%
Gain YTD91.76066.412138%
P/E Ratio1515.20N/A-
Revenue3.21B250K1,284,000%
Total Cash2.73B109M2,500%
Total Debt1.31B649K201,541%
FUNDAMENTALS RATINGS
ALNY: Fundamental Ratings
ALNY
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
8
SMR RATING
1..100
28
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
43
SEASONALITY SCORE
1..100
30

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALNYRPTX
RSI
ODDS (%)
Bullish Trend 4 days ago
67%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
77%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
65%
Bullish Trend 4 days ago
85%
MACD
ODDS (%)
Bearish Trend 4 days ago
66%
Bullish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
72%
Bullish Trend 4 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
66%
Bullish Trend 4 days ago
84%
Advances
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 8 days ago
83%
Declines
ODDS (%)
Bearish Trend 7 days ago
64%
Bearish Trend 12 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
82%
Aroon
ODDS (%)
Bullish Trend 4 days ago
71%
Bullish Trend 4 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ALNY
Daily Signal:
Gain/Loss:
RPTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RCGCF0.090.01
+8.22%
ROSCAN GOLD CORP.
SHCAY1.230.01
+0.65%
Sharp Corp.
NETWF0.09N/A
N/A
Network Media Group Inc.
TRUHF0.14N/A
N/A
Truly International Holdings Ltd.
JRONF21.50N/A
N/A
Jeronimo Martins, SGPS, SA

ALNY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALNY has been loosely correlated with ARGX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ALNY jumps, then ARGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALNY
1D Price
Change %
ALNY100%
+1.37%
ARGX - ALNY
47%
Loosely correlated
-0.62%
IONS - ALNY
45%
Loosely correlated
+0.04%
SGMO - ALNY
42%
Loosely correlated
-0.67%
AXSM - ALNY
38%
Loosely correlated
+0.34%
BBIO - ALNY
37%
Loosely correlated
+0.40%
More

RPTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RPTX has been loosely correlated with INO. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if RPTX jumps, then INO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RPTX
1D Price
Change %
RPTX100%
-1.36%
INO - RPTX
51%
Loosely correlated
+5.10%
BCYC - RPTX
50%
Loosely correlated
+2.33%
CADL - RPTX
42%
Loosely correlated
+3.25%
LVTX - RPTX
40%
Loosely correlated
N/A
ALNY - RPTX
38%
Loosely correlated
+1.37%
More